Considering as the common regulator of tumor angiogenesis, including endothelial cell activation, proliferation and migration, vascular endothelial growth factor (VEGF) pathway has been validated as a therapeutic approach for patients with several tumor types8. The gene discussed is VEGFA; the disease is neoplasm.